Erich T, Schellekens J, Bouter A, Van Kranen J, Brouwer E, Verhoef J
Eijkman-Winkler Laboratory for Microbiology, University of Utrecht, The Netherlands.
J Immunol. 1989 Dec 15;143(12):4053-60.
A detailed characterization of binding specificity and cross-reactivity of three antilipid A murine mAb was performed. Binding characteristics of these three mAb were investigated against Ag (ReLPS, lipid A, derivatives of lipid A) in solid phase (ELISA) and in fluid phase (C consumption, inhibition studies), and upon incorporation in membranes (E: passive hemolysis assay, and liposomes: inhibition studies). Cross-reactivity with heterologous Ag was investigated in ELISA (LPS, Gram-negative bacteria) and immunoblot experiments (LPS). The binding specificity of mAb 26-5 (IgG2b), raised against synthetic lipid A, was located in the hydrophilic region of biphospholipid A and was also exposed after membrane incorporation of lipid A or after preincubation of lipid A with polymyxin B (PMX). mAb 26-20 (IgM), also raised against synthetic lipid A, showed binding specificity for the hydrophobic region of lipid A: no binding to membrane-associated lipid A could be demonstrated, and binding in ELISA could be blocked very efficiently by PMX. The reaction pattern of mAb 8-2 (IgM), raised against the heat-killed Re mutant of Salmonella typhimurium, was in part similar to that of mAb 26-20. However, inhibition of binding with PMX was less efficient and a high specificity for ReLPS, also after membrane incorporation of this Ag, was demonstrated. In contrast to mAb 26-5 and 26-20, mAb 8-2 showed extensive cross-reactivity with heterologous LPS preparations and heat-killed as well as live Gram-negative bacteria. It is concluded that each of the three mAb binds to a different antigenic epitope in lipid A and that exposure of those epitopes for antibody binding is restricted in a differential manner, depending on mode of Ag presentation. The here defined reaction patterns provide a basis for the interpretation of potential inhibitory effects on in vitro and in vivo biologic (and toxic) activities of endotoxins and Gram-negative bacteria.
对三种抗脂质A小鼠单克隆抗体的结合特异性和交叉反应性进行了详细表征。针对固相(酶联免疫吸附测定)和液相(补体消耗、抑制研究)中的抗原(粗糙脂多糖、脂质A、脂质A衍生物)以及掺入膜中后(红细胞:被动溶血测定,脂质体:抑制研究),研究了这三种单克隆抗体的结合特性。在酶联免疫吸附测定(脂多糖、革兰氏阴性菌)和免疫印迹实验(脂多糖)中研究了与异源抗原的交叉反应性。针对合成脂质A产生的单克隆抗体26 - 5(IgG2b)的结合特异性位于双磷脂A的亲水区域,在脂质A掺入膜后或脂质A与多粘菌素B(PMX)预孵育后也会暴露。同样针对合成脂质A产生的单克隆抗体26 - 20(IgM)显示出对脂质A疏水区域的结合特异性:无法证明其与膜相关脂质A的结合,并且在酶联免疫吸附测定中的结合可被PMX非常有效地阻断。针对鼠伤寒沙门氏菌热灭活粗糙突变体产生的单克隆抗体8 - 2(IgM)的反应模式部分类似于单克隆抗体26 - 20。然而,用PMX抑制结合的效率较低,并且在该抗原掺入膜后也显示出对粗糙脂多糖的高特异性。与单克隆抗体26 - 5和26 - 20相反,单克隆抗体8 - 2与异源脂多糖制剂以及热灭活和活的革兰氏阴性菌显示出广泛的交叉反应性。得出的结论是,这三种单克隆抗体各自结合脂质A中不同的抗原表位,并且这些表位对于抗体结合的暴露以不同方式受到限制,这取决于抗原呈递方式。这里定义的反应模式为解释对内毒素和革兰氏阴性菌的体外和体内生物学(和毒性)活性的潜在抑制作用提供了基础。